113 related articles for article (PubMed ID: 32314603)
21. Chronic Myeloid Leukemia: Part I-Real-World Treatment Patterns, Healthcare Resource Utilization, and Associated Costs in Later Lines of Therapy in the United States.
Atallah EL; Maegawa R; Latremouille-Viau D; Rossi C; Guérin A; Wu EQ; Patwardhan P
J Health Econ Outcomes Res; 2022; 9(2):19-29. PubMed ID: 35979528
[No Abstract] [Full Text] [Related]
22. The Impact of Systemic Therapy Beyond First-line Treatment for Advanced Cervical Cancer.
McLachlan J; Boussios S; Okines A; Glaessgen D; Bodlar S; Kalaitzaki R; Taylor A; Lalondrelle S; Gore M; Kaye S; Banerjee S
Clin Oncol (R Coll Radiol); 2017 Mar; 29(3):153-160. PubMed ID: 27838135
[TBL] [Abstract][Full Text] [Related]
23. Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With First-line Therapies for Medicare Patients 65 Years and Older With Advanced Non-small-cell Lung Cancer: A Retrospective Study.
Bittoni MA; Arunachalam A; Li H; Camacho R; He J; Zhong Y; Lubiniecki GM; Carbone DP
Clin Lung Cancer; 2018 Sep; 19(5):e629-e645. PubMed ID: 29885945
[TBL] [Abstract][Full Text] [Related]
24. Economic burden of multiple myeloma among patients in successive lines of therapy in the United States.
MacEwan JP; Batt K; Yin W; Peneva D; Sison S; Vine S; Chen C
Leuk Lymphoma; 2018 Apr; 59(4):941-949. PubMed ID: 28805105
[TBL] [Abstract][Full Text] [Related]
25. Comparison of demographics, treatment patterns, health care utilization, and costs among elderly patients with extensive-stage small cell and metastatic non-small cell lung cancers.
Karve SJ; Price GL; Davis KL; Pohl GM; Smyth EN; Bowman L
BMC Health Serv Res; 2014 Nov; 14():555. PubMed ID: 25392276
[TBL] [Abstract][Full Text] [Related]
26. Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States.
Liu J; Emond B; Maiese EM; Lafeuille MH; Lefebvre P; Ghelerter I; Wu C; Hurteau JA; Thaker PH
Curr Med Res Opin; 2022 Nov; 38(11):1935-1945. PubMed ID: 35975577
[TBL] [Abstract][Full Text] [Related]
27. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
[TBL] [Abstract][Full Text] [Related]
28. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
[No Abstract] [Full Text] [Related]
29. Chemotherapy use, outcomes, and costs for older persons with advanced non-small-cell lung cancer: evidence from surveillance, epidemiology and end results-Medicare.
Ramsey SD; Howlader N; Etzioni RD; Donato B
J Clin Oncol; 2004 Dec; 22(24):4971-8. PubMed ID: 15611512
[TBL] [Abstract][Full Text] [Related]
30. Trends in end-of-life care and health care spending in women with uterine cancer.
Margolis B; Chen L; Accordino MK; Clarke Hillyer G; Hou JY; Tergas AI; Burke WM; Neugut AI; Ananth CV; Hershman DL; Wright JD
Am J Obstet Gynecol; 2017 Oct; 217(4):434.e1-434.e10. PubMed ID: 28709581
[TBL] [Abstract][Full Text] [Related]
31. Increasing economic burden of tyrosine kinase inhibitor treatment failure by line of therapy in chronic myeloid leukemia.
McGarry LJ; Chen YJ; Divino V; Pokras S; Taylor CR; Munakata J; Nieset CC; Huang H; Jabbour E; Malone DC
Curr Med Res Opin; 2016; 32(2):289-99. PubMed ID: 26566171
[TBL] [Abstract][Full Text] [Related]
32. Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.
Hurry M; Hassan S; Seung SJ; Walton RN; Elnoursi A; McGee JD
J Health Econ Outcomes Res; 2021; 8(2):114-121. PubMed ID: 34993257
[No Abstract] [Full Text] [Related]
33. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
34. Cost of care for the initial management of cervical cancer in women with commercial insurance.
Blanco M; Chen L; Melamed A; Tergas AI; Khoury-Collado F; Hou JY; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2021 Mar; 224(3):286.e1-286.e11. PubMed ID: 32818476
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.
Bao Y; Maciejewski RC; Garrido MM; Shah MA; Maciejewski PK; Prigerson HG
J Pain Symptom Manage; 2018 Apr; 55(4):1113-1121.e3. PubMed ID: 29241809
[TBL] [Abstract][Full Text] [Related]
36. Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K; Castellano T; Washington C; Ting J; Surinach A; Kirshner C; Chhatwal J; Ayer T; Moore K
Gynecol Oncol Rep; 2022 Dec; 44(Suppl 1):101101. PubMed ID: 36506039
[TBL] [Abstract][Full Text] [Related]
37. Factors associated with receipt of second-line recurrent or metastatic cervical cancer treatment in the United States: A retrospective administrative claims analysis.
Sonawane K; Castellano T; Washington C; Ting J; Surinach A; Kirshner C; Chhatwal J; Ayer T; Moore K
Gynecol Oncol Rep; 2022 Dec; 44():101121. PubMed ID: 36589508
[TBL] [Abstract][Full Text] [Related]
38. Total Medicare Costs Associated With Diagnosis and Treatment of Prostate Cancer in Elderly Men.
Trogdon JG; Falchook AD; Basak R; Carpenter WR; Chen RC
JAMA Oncol; 2019 Jan; 5(1):60-66. PubMed ID: 30242397
[TBL] [Abstract][Full Text] [Related]
39. Real-World Treatment Patterns and Economic Burden Following First-Line Trastuzumab in Patients with Metastatic Gastric Cancer in the USA.
Barzi A; Lin F; Song J; Lam C; Nie X; Noman A; Kwong WJ
Drugs Real World Outcomes; 2023 Sep; 10(3):395-404. PubMed ID: 37540381
[TBL] [Abstract][Full Text] [Related]
40. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
